Logo

NeoGenomics Nabs Cancer Testing Contract With HealthTrust Purchasing Group

Mar 02, 2020 | staff reporter

NEW YORK – NeoGenomics announced Monday that it has been awarded a three-year contract to serve as the cornerstone laboratory for HealthTrust Purchasing Group's Specialized Reference Laboratory for Oncology & Cancer Genetics.

Financial and other terms of the deal were not disclosed.

The agreement, which went into effect March 1, secures standardized corporate pricing for HPG-affiliated facilities and providers across the US and provides access to NeoGenomics' cancer diagnostic and oncology genetics testing services.

Fort Myers, Florida-based NeoGenomics is the first specialized oncology laboratory to become a preferred in-network lab option for HPG members, said CEO and Chairman Douglas VanOort in a statement.

Filed under

Business News
Molecular Diagnostics
Cancer
North America
Neogenomics
Breaking News
The Scan

Machine Learning Helps ID Molecular Mechanisms of Pancreatic Islet Beta Cell Subtypes in Type 2 Diabetes

The approach helps overcome limitations of previous studies that had investigated the molecular mechanisms of pancreatic islet beta cells, the authors write in their Nature Genetics paper.

Culture-Based Methods, Shotgun Sequencing Reveal Transmission of Bifidobacterium Strains From Mothers to Infants

In a Nature Communications study, culture-based approaches along with shotgun sequencing give a better picture of the microbial strains transmitted from mothers to infants.

Microbial Communities Can Help Trees Adapt to Changing Climates

Tree seedlings that were inoculated with microbes from dry, warm, or cold sites could better survive drought, heat, and cold stress, according to a study in Science.

A Combination of Genetics and Environment Causes Cleft Lip

In a study published in Nature Communications, researchers investigate what combination of genetic and environmental factors come into play to cause cleft lip/palate.